hemopericardium and cardiac tamponade should be suspected in subjects with a history of percutaneous closure of an ASD who present with acute chest pain or shortness of breath and signs of hemodynamic instability.Case Report: The incidence of Bordetella pertussis has been increasing recently, with a marked rise noted in 2012, with 48,000 cases reported by the CDC that year. The jump is attributed to resistance to vaccination as well as lack of public awareness of booster immunizations. While the disease carries significant morbidity in children, its course is typically mild in adults. At our facility, we admitted a 33-year-old female with history of mild intermittent asthma who works in a day care center. She reported a 6-day history of upper respiratory symptoms. She had been compliant with albuterol, Medrol dosepack, and amoxicillin prescribed by her primary care, with minor improvement in symptoms. In the ER, she was found be in impending respiratory failure, with tachypnea, stridor, and pulse oxygen saturation of 84% on non-rebreather mask. Emergent intubation was performed using a glidoscope and bougie with a 6.0 endotracheal tube. Following stabilization of the airway, a CT of the neck showed edematous infra and supraglottic airway encompassing the ETT. Laboratory data revealed lactic acidosis and bandemia. The patient was given intramuscular epinephrine and started on azithromycin, ceftriaxone, and steroids. Workup for hereditary angioedema, blood and sputum cultures, and viral multiplex PCR were negative. On day 3 of hospitalization, the patient had a positive cuff-leak test; the next day, she was taken to the operating room for extubation, which was well tolerated. She was discharged on hospital day 6 on prednisone taper. Following discharge, serology for pertussis showed elevated IgA at 52 (normal range <50), consistent with acute pertussis. This case reinforces the importance to deliver booster vaccination in all adults. In our case, our patient had underlying reactive airway disease and was frequently exposed to sick children, some of whom may not have completed their vaccination series due to age. Although pertussis rarely causes disease in adults, our patient nearly died due to severe laryngeal edema.
BackgroundExtracorporeal membrane oxygenation (ECMO) has been used in various clinical settings, such as acute respiratory distress syndrome, cardiogenic shock and refractory septic shock. One of the associated risks is acquisition of infections during bypass because of the multiple cannulation sites. The purpose of this study was to evaluate the predictors of healthcare associated infections (HAI) and mortality in adult patients on ECMO.MethodsThis was a retrospective descriptive study at a 1550 bed University- affiliated tertiary medical center in Miami, Florida. We looked at patients over 18 years old on ECMO for > 48 hours between January 1–August 31, 2016. The presence of an infection before ECMO placement or acquired during ECMO support were noted. Only culture- proven infections were included. The primary outcome was to identify risk factors associated with HAI or mortality.Results40 patients undergoing ECMO during the study period were identified. 25 patients met the inclusion criteria and were included in the analysis. During a total of 364 ECMO days, 12 patients out of 25 had microbiologically proven infection (48 %). There were 7 ventilator associated pneumonias (41%), 5 bacteremias (29%), 2 pleural empyemas (12%), 2 Clostridium difficile colitis (12%) and 1 mediastinitis (6%). Candida species were the predominant blood isolates (60%). The rate of infection per 1,000 ECMO days was 46.7.The overall in-hospital mortality was 64%. There was no impact of infection on mortality, length of ICU,or hospital stay. ECMO use for < 7 days was associated with overall less episodes of infection vs ECMO use for > 7 days. (P-value 0.0136, OR 0.089, CI: 0.01–0.6). Charlson-comorbidity score of 5 or more was associated with higher episodes of bacteremia (P = 0.0023, OR = 16, CI = 1.38–185.41).ConclusionInfections did not have an impact on mortality. Patients on ECMO for less than 8 days had less episodes of infections. Patients with Charlson-comorbidity index of 5 or more were associated with higher episodes of bacteremia. Further prospective cohort studies are necessary to address causality and to determine infection and mortality predictors that can be modified for patients undergoing ECMO.Disclosures All authors: No reported disclosures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.